Navigation Links
Scientists take up golf to prove long-standing theory of cell stickiness
Date:10/4/2011

State-of-the-art, highly-sensitive golf clubs, developed by scientists, regularly catch the eye of golf's elite; however before the likes of Rory McIlroy get excited this time, this new golf putter is being put to use in microbiology laboratories.

The 'micro putter', developed in a study published today, 5 October 2011, in IOP Publishing's journal Measurement Science and Technology, has been designed to test the "stickiness" of single cells.

With a length of 240 micrometres, a width of 30 micrometres and a tip of just two micrometres, golfers would not even be able to see this new putter; one micrometre is equal to one-millionth of a metre.

Researchers from Nagoya University in Japan are using the micro putter to nudge individual yeast cells placed on a variety of surfaces to test cell adhesion.

Cell adhesion is the ability of a single cell to stick to other cells, or an exterior material, and has long been theorised as a way of testing if a cell is dead or alive.

According to the "cell adhesion model", the more a cell sticks the greater number of chemical bonds it has on its surface. A dead cell would have fewer chemical bonds on its surface so would therefore stick less than a living cell.

The research team has provided compelling evidence that this theory is correct, showing that a cell's adhesion is decreased by more than half once it's died.

Compared to conventional cell testing whereby averages are obtained by staining dead and living colonies with special dyes, the micro-putter could provide a fast and simple approach to testing individual cells and provide a more precise understanding of the biological processes that occur.

Co-author, Yajing Shen, said, "The identification of cell viability is very important in the biological and medical field. Take disease therapy for example: cell viability measurements could be used to evaluate the death of cancerous cells or evaluate cell damage due to toxins."

To fabricate the intricate details of the micro putter, charged particles were fired at a cantilever, using a technique known as focused ion beam (FIB), to remove material from its surface.

The micro putter was used to test the adhesion of live and dead yeast cells that were cultured in the lab for two days. The tests were carried out in an environmental scanning electron microscope (ESEM) a high-powered microscope that allows the user to image specimens when they are wet, meaning cells can be visualised in their natural environment.

Once inside the ESEM, the yeast cells were delicately placed on three surfaces of varying cell adhesion tungsten, gold and indium tin oxide and nudged with the micro putter until they were removed from their spot. The microscope was able to capture images of the movement of the cells whilst the tiny deflection of the putter was recorded as a measure of the cell's adhesion.

The adhesion force of a living cell was approximately 19 micronewtons, three times the force of a dead cell which had a value of approximately six micronewtons, confirming the 'cell adhesion model'.

"We hope the micro putter can be used to evaluate the actual health conditions of cells in the future. Combined with a single cell surgery technique, the micro putter could help to understand the mechanisms of disease and develop effective new drugs," continued Shen.


'/>"/>

Contact: Michael Bishop
michael.bishop@iop.org
01-179-301-032
Institute of Physics
Source:Eurekalert

Related biology technology :

1. Sheffield scientists shine a light on the detection of bacterial infection
2. Scientists observe how superconducting nanowires lose resistance-free state
3. Controlling silicon evaporation allows scientists to boost graphene quality
4. Scientists utilize breath and sweat to detect trapped humans
5. Neuroscientists produce guide for ultrasound use to treat brain disorders in clinical emergencies
6. Scientists create mammalian cells with single chromosome set
7. Scripps research scientists find clue to cause of childhood hydrocephalus
8. Leicester scientists deploy space-age technologies at science-fiction style sick bay
9. Scientists develop new technologies for understanding bacterial infections
10. Syngene Expands Ongoing Relationship with CAS to Provide SciFinder® to All Its Scientists
11. A*Star scientists discover how to combat hospital-acquired infections and life-threatening toxins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... , Feb. 23, 2017  Seattle,s upscale Capitol Hill neighborhood, ... strange place for a head lice treatment salon to set ... a Tuscan restaurant and a French bistro on E Madison ... "We aren,t just any old lice clinic, we pride ourselves ... comfortable, and release some of the stigma associated with lice. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can ... adiponectin, uric acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect ... SalivaLab , the relationship between insulin and other relevant biomarkers can be extensively ...
(Date:2/23/2017)... Washington, USA, and CARDIFF, UK (PRWEB) , ... ... ... the international society for optics and photonics , have been named Fellows of ... individual’s significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, ...
Breaking Biology Technology:
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
(Date:2/2/2017)...   TapImmune, Inc. (NASDAQ: ... the development of innovative peptide and gene-based immunotherapeutics ... metastatic disease, announced today it has successfully completed ... second clinical lot of TPIV 200, the company,s ... manufactured vaccine product will be used to supply ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
Breaking Biology News(10 mins):